These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32525023)

  • 1. A survey of within-host and between-hosts modelling for antibiotic resistance.
    Tetteh JNA; Matthäus F; Hernandez-Vargas EA
    Biosystems; 2020 Oct; 196():104182. PubMed ID: 32525023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modelling for antibiotic resistance control policy: do we know enough?
    Knight GM; Davies NG; Colijn C; Coll F; Donker T; Gifford DR; Glover RE; Jit M; Klemm E; Lehtinen S; Lindsay JA; Lipsitch M; Llewelyn MJ; Mateus ALP; Robotham JV; Sharland M; Stekel D; Yakob L; Atkins KE
    BMC Infect Dis; 2019 Nov; 19(1):1011. PubMed ID: 31783803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting conjugation as a tool in the fight against antibiotic resistance.
    Graf FE; Palm M; Warringer J; Farewell A
    Drug Dev Res; 2019 Feb; 80(1):19-23. PubMed ID: 30343487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic Cycling and Antibiotic Mixing: Which One Best Mitigates Antibiotic Resistance?
    Beardmore RE; Peña-Miller R; Gori F; Iredell J
    Mol Biol Evol; 2017 Apr; 34(4):802-817. PubMed ID: 28096304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and modelling of antibacterial combination regimens.
    Rao GG; Li J; Garonzik SM; Nation RL; Forrest A
    Clin Microbiol Infect; 2018 Jul; 24(7):689-696. PubMed ID: 29269090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of antibiotic resistance: insight into the roles of molecular mechanisms of resistance and treatment context.
    Maclean RC; Hall AR; Perron GG; Buckling A
    Discov Med; 2010 Aug; 10(51):112-8. PubMed ID: 20807471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic-non-antibiotic combinations for combating extremely drug-resistant Gram-negative 'superbugs'.
    Schneider EK; Reyes-Ortega F; Velkov T; Li J
    Essays Biochem; 2017 Feb; 61(1):115-125. PubMed ID: 28258235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrofurans: Revival of an "old" drug class in the fight against antibiotic resistance.
    Le VVH; Rakonjac J
    PLoS Pathog; 2021 Jul; 17(7):e1009663. PubMed ID: 34237108
    [No Abstract]   [Full Text] [Related]  

  • 9. Send more data: a systematic review of mathematical models of antimicrobial resistance.
    Birkegård AC; Halasa T; Toft N; Folkesson A; Græsbøll K
    Antimicrob Resist Infect Control; 2018; 7():117. PubMed ID: 30288257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.
    Rayner CR; Smith PF; Andes D; Andrews K; Derendorf H; Friberg LE; Hanna D; Lepak A; Mills E; Polasek TM; Roberts JA; Schuck V; Shelton MJ; Wesche D; Rowland-Yeo K
    Clin Pharmacol Ther; 2021 Apr; 109(4):867-891. PubMed ID: 33555032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of spatiotemporal antibiotic inhomogeneities on the evolution of resistance.
    Steel H; Papachristodoulou A
    J Theor Biol; 2020 Feb; 486():110077. PubMed ID: 31715181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Antibiotic Resistance.
    Munita JM; Arias CA
    Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical model predicts anti-adhesion-antibiotic-debridement combination therapies can clear an antibiotic resistant infection.
    Roberts PA; Huebinger RM; Keen E; Krachler AM; Jabbari S
    PLoS Comput Biol; 2019 Jul; 15(7):e1007211. PubMed ID: 31335907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed antibiotic exposure induces population collapse in enterococcal communities with drug-resistant subpopulations.
    Hallinen KM; Karslake J; Wood KB
    Elife; 2020 Mar; 9():. PubMed ID: 32207406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome as a tool and a target in the effort to address antimicrobial resistance.
    Relman DA; Lipsitch M
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):12902-12910. PubMed ID: 30559176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of "spillover" in antibiotic resistance.
    Olesen SW; Lipsitch M; Grad YH
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29063-29068. PubMed ID: 33139558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.
    Temime L; Hejblum G; Setbon M; Valleron AJ
    Epidemiol Infect; 2008 Mar; 136(3):289-98. PubMed ID: 17767792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofilms: Microbial Shelters Against Antibiotics.
    Hathroubi S; Mekni MA; Domenico P; Nguyen D; Jacques M
    Microb Drug Resist; 2017 Mar; 23(2):147-156. PubMed ID: 27214143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus.
    Morel CM; Lindahl O; Harbarth S; de Kraker MEA; Edwards S; Hollis A
    J Antibiot (Tokyo); 2020 Jul; 73(7):421-428. PubMed ID: 32203126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance.
    Larsen EM; Johnson RJ
    Drug Dev Res; 2019 Feb; 80(1):33-47. PubMed ID: 30302779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.